Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of AG-013736 in combination with other standard of care
medication in patients with first line metastatic colorectal cancer.